Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David Dermot Patrick Laffan"'
Autor:
Erwin Irdam, Christopher J. Welch, Aaron S. Cote, Jean W. Tom, Pierre Boulas, Joel M. Hawkins, Kenneth M. Wells, Charles D. Papageorgiou, David Dermot Patrick Laffan, Margaret M. Faul, Purdie Mark, Rahn McKeown, Scott A. May, Steven J. Wittenberger, Srinivas Tummala, Kevin D. Seibert, Nicholas Murray Thomson, Frederick Hicks, Antonio Christian Ferretti, Paul Frank Fernandez, Keith Horspool, Shailendra Bordawekar, Bing-Shiou Yang
Publikováno v:
Organic Process Research & Development. 21:414-419
The creation of the Enabling Technologies Consortium (ETC) is described. The ETC fosters precompetitive collaborations aimed at the development and evaluation of new enabling technologies for pharmaceutical research and development, with an initial f
Autor:
Guy C. Lloyd-Jones, David Dermot Patrick Laffan, Jennifer L. Slaughter, Philip D. Wall, Alexandra J. Parker
Publikováno v:
Tetrahedron. 62:11402-11412
Dibenzylideneacetone (8) reacts with in situ-generated allylindium halide reagents to yield the product of a homoallyl-cyclopropanation reaction: 2-(3″-butenyl)-1,1-bis[(E)-2′-phenylethenyl]cyclopropane (9), which proceeds via step-wise cleavage
Publikováno v:
Tetrahedron Letters. 45:6541-6543
Attempts to convert a propargylic alcohol bearing an imidazolone substituent to the corresponding aldehyde under Parikh-Doering conditions gave an alpha,beta-unsaturated-beta-methylsulfanyl aldehyde, which cyclised under mildly acidic conditions. (C)
Autor:
David Dermot Patrick Laffan, Ian Shepperson, Teresa Martínez del Campo, Jennifer L. Slaughter, Guy C. Lloyd-Jones, Erik Kühnel
Publikováno v:
Angewandte Chemie (International ed. in English). 46(37)
Publikováno v:
ChemInform. 37
The purpose of this perspective is to indicate the range of chemistries used in the manufacture of drug candidate molecules and to highlight certain gaps in current technologies. To do this a survey was carried out of chemical syntheses within the Pr